低分子肝素治疗非ST段抬高急性冠状动脉综合征的疗效

The efficacy observation of low-molecular weight heparins therapy for acute coronary syndrome with non-ST-segment elevation

目的探讨低分子肝素对非ST段抬高急性冠状动脉综合征的疗效。方法52例非ST段抬高急性冠状动脉综合征患者在常规抗心肌缺血治疗基础上予以低分子肝素治疗。结果非ST段抬高急性冠状动脉综合征缓解率达92．3％,心电图改善率达80．8％,除4例局部注射处出现瘀斑外,余未见不良反应。结论低分子肝素对急性非ST段抬高冠状动脉综合征有较好的疗效和安全性。

Objective To explore the effect of low-molecular weight heparins（LMWH） treating non-ST- segment elevation acute coronary syndrome （NSTEACS）.Mcthods 52 NSTEACS cases routinely received anti-myocardial ischemia therapy in addition to LMWH. Results 92.3% of the eases responed on LMWH treatment,80.8% obtained improvement in electrocardiogram.Except 4 cases appeared ecchymosis in injection site hypodermis, others had no adverse reaction.Conclusion LMWH has better effect in safe application for treating NSTE ACS.